Welcome to the summer edition of European Neurological Review!
This issue is introduced by one of the newest additions to our Editorial Board, Leontino Battistin, and opens with an expert interview with Dawn Langdon on cognitive assessment in multiple sclerosis (MS). Also on the topic of MS, we have a review on the therapeutic use of sphingosine-1-phoshate receptor modulators (Patrick Vermersch), and a commentary on the need to improve patient education for women with MS on issues around the ability to have children and family planning (Janet Manson).
Editorials in this issue cover standards of residential care for people with dementia across Europe (Alzheimer Europe), current trends of thinking in clinical neuroscience (Leontino Battistin) and patient burden and the need for new therapeutic targets in myasthenia gravis (Saiju Jacob). Eugenio Mercuri et al. review the need for early diagnosis and treatment of Duchenne muscular dystrophy (DMD) with a focus on the use of ataluren, the first disease-modifying therapy for treating DMD caused by nonsense mutations, and two groups led by Parisa Gazerani present original research in the field of pain – investigating whether an association exists between ABO blood types and post-operative pain, and exploring the prevalence and pattern of pain in patients with neuromyelitis optica spectrum disorder (NMOSD).
We hope you enjoy this edition, which will be distributed at the European Academy of Neurology (EAN) annual meeting in Lisbon - please do stop by the EAN literature stand to pick up your free copy.
We are now accepting submission to our winter edition, and welcome you to submit you manuscript here.